What’s New At IMAGIA?

Follow the latest news and announcements from Imagia.

What’s New At IMAGIA?

Follow the latest news and announcements from Imagia.

May 24, 2019 – press release 

Federal Government Awards $49M to Terry Fox Research Institute and Imagia led Consortium to Accelerate Medical Breakthroughs

The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, announced an investment of up to $49M from the Strategic Innovation Fund (SIF) as part of the Stream 4 – Health and Biosciences competition. This award, together with $108M in-cash and $165M in-kind contributions from 97 consortium partners, supports a Digital Health and Discovery Platform (DHDP) that will combine Canadian expertise in artificial intelligence (AI) and precision medicine to improve healthcare for Canadians. The joint endeavour will catalyze collaborations with industry to stimulate commercialization of home-grown research discoveries.


dEcember 5, 2018 – press release

The Government of Canada invests in artificial intelligence and creates close to 1,000 middle-class jobs

Six Montréal-based companies to scale up and expand into new markets.

The Government of Canada is committed to supporting Canada’s high growth-potential businesses to innovate, to increase their productivity and competitiveness, and to access new markets, thereby contributing to the economic growth of regions, job creation and a better quality of life for Canadians.


november 23, 2018 – Press Release

Christie Innomed & Imagia Pioneer Advanced AI Capabilities for Hospital Systems to bring Automated Value Creation

Christie Innomed, a leading Enterprise Imaging provider in Canada and Artificial intelligence (AI) platform provider Imagia, have entered into a collaborative agreement. Our common objective is to mobilize relevant scientific and clinical expertise, bring artificial intelligence capabilities to major international hospitals and accelerate the potential for AI-driven healthcare solutions.

March 6, 2018 – communiqué

Clinician-friendly ai enables personalized healthcare discoveries in the cloud

Researchers at the McGill University Health Center are developing new early diagnostics solutions to deliver better integrated care in personalized medicine, by non-invasively assessing the molecular and clinical characteristics of lung tumors from routine clinical images, an emerging field known as radiomics. “In today’s complex healthcare environment, the development of quantitative biomarkers in cancer imaging is revolutionizing predictive medicine,” said McGill University Health Center (MUHC) Chair of Diagnostic Radiology and Professor Dr. Benoit Gallix.

may 7, 2018 – press release

Olympus Announces Co-Development
Agreement with AI4GI

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced its co-development agreement with AI4GI, a commercial joint venture between Satis Operations and Imagia. Their Artificial Intelligence (AI) solution for real-time clinical decision support during screening and surveillance colonoscopy procedures will be exclusively offered by Olympus America Inc. (OAI). This co-development agreement is intended to raise the bar for all physicians to ultimately improve clinical outcomes, reduce overall costs and enhance the quality of life for patients. 

march 26, 2018 – press release

Artificial intelligence applied to oncology:
Quebec grants its first
$3 million to Imagia

The Government of Québec awards, through the BioMed Propulsion program, a $ 3 million loan to Imagia to support an artificial intelligence project applied to personalized healthcare.

« We are proud to be the first AI Healthcare company to receive this funding. It sends a clear message about the importance of supporting both research and local industry. This collaborative ecosystem between industry and research will maintain and attract the talent specialized in AI in Québec.»

Alexandre Le Bouthillier,
Ph.D., co-founder of Imagia

February 8, 2018 – press release

In vivo science and artificial intelligence join forces to advance tools in cancer treatment and management

It will become easier to discover imaging biomarkers and identify digital surrogates for modern end-points in personalized therapies, thanks to a partnership between Sylvain Meloche – Principal Investigator within the signaling and cell growth research unit at the Institute for Research in Immunology and Cancer (IRIC)  along with his team, and Imagia, an AI-driven personalized healthcare company.


november 15, 2017 – communiqué

Imagia completes acquisition
of Cadens Medical Imaging

Imagia, a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems, today announced the completion of its acquisition of Cadens Medical Imaging (Cadens), a technology leader in medical imaging software.

“This strategic transaction will significantly accelerate Imagia’s mission of delivering AI-driven accessible personalized healthcare solutions,” said Frédéric Francis, CEO of Imagia.